Sectoral Asset Management

Rounds

• I IantrekSurgical glaucoma therapy targeting the uveoscleral outflow pathway $42MSeries C · 20 Aug
• N Neuros MedicalMaker of the FDA-cleared Altius nerve-block system for post-amputation pain. $56MSeries D · 9 Jul

No round matches these filters.

Often invests with

• U.S. Venture Partners2
• aMoon Fund1
• Amzak Health1
• Civilization Ventures1
• EQT Life Sciences1
• Osage University Partners1
• Radius Special Situations Fund1
• Visionary Ventures1